VRTX:Vertex Pharmaceuticals Incorporated Snapshot | Charting | News | Options
$505.75 NASDAQ 4:05p ET
August 3 '26 		Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story Top Stories on VRTX
    No News Available
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Follow...
    11:03a ET July 21 '26 GlobeNewswire
    A Diabetes Therapy Just Locked In Its Cell Supplier, and the Race to ...
    9:01a ET July 21 '26 CNW Group
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Follow...
    10:30a ET July 14 '26 GlobeNewswire
    The Longevity Protein Race Reaches Manufacturing: One Microcap Just C...
    9:03a ET July 8 '26 CNW Group
    Anti-Aging Cell Therapy Reaches Major GMP Milestone as Wave of Clinic...
    9:16a ET May 28 '26 CNW Group

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2026 All rights reserved.